
Apotinib Imatinib
Apotinib Imatinib (400mg) oral solid — targeted therapy for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). WHO-GMP certified, export-ready.
400mg
Apotinib Imatinib 400mg
10 Tablets per strip
NexCure Health
Pricing and availability are confirmed by our team after checking the product, quantity, destination rules, and required documentation.
Bulk quotes, documentation, and shipping options are handled manually after prescription, buyer, and destination checks where applicable.
400mg Apotinib Imatinib Tablets IP contains Apotinib Imatinib 400mg, a targeted therapy agent. This product works as a tyrosine kinase inhibitor that blocks BCR-ABL fusion protein activity. It is primarily indicated for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Manufactured by NexCure Health in compliance with WHO-GMP standards, each batch undergoes rigorous quality testing including HPLC assay, dissolution testing, and stability studies. Available for pharmaceutical export with Certificate of Analysis and full regulatory documentation.